IMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products

Stock News

05/22

IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1186724819"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186724819\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186724819?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-22 21:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186724819","market":"hk","top_or_hot":-1,"title":"IMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products","media":"Stock News","content":"<p>IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIMMUNEONCO-B (01541) Redeems HK$205 Million Shenwan Products and Subscribes to HK$212 Million Shenwan Hongyuan Wealth Management Products\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-05-22 21:28</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1564","symbol_name":"中資券商股","start_time":0,"source_url":"","article_id":"1186724819","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186724819","pubTimestamp":1779456509,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1564":"中资券商股","01541":"宜明昂科-B","BK0028":"国家队","BK0012":"证金概念","BK0276":"资本市场","BK0183":"MSCI概念","BK0188":"融资融券","BK1161":"生物科技","000166":"申万宏源","BK1147":"投资银行业与经纪业","06806":"申万宏源"},"translate_title":"IMMUNEONCO-B(01541)赎回2.05亿港元申万产品及认购2.12亿港元申万宏源理财产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06806":1,"000166":1,"01541":1},"content_text":"IMMUNEONCO-B (01541) announced that on May 22, 2026, the company notified Shenwan Hongyuan Securities (Hong Kong) to redeem, in cash, Shenwan products totaling HK$205 million, which constituted all Shenwan products held by the company at that time. The estimated income from this redemption is approximately HK$4.969 million, representing unaudited interest income generated from the redemption transaction. Following the redemption, the group will no longer hold any outstanding wealth management products issued by Shenwan Hongyuan Securities (Hong Kong). Additionally, on May 22, 2026, the company agreed to subscribe to wealth management products from Shenwan Hongyuan Securities (Hong Kong) with a total value of HK$212 million. This subscription is funded by the group's internal surplus cash reserves.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}